Home > PS Ratio > INDOCO REMEDIES

INDOCO REMEDIES
PS (Price/Sales) Ratio

The Current P/S Ratio of INDOCO REMEDIES is 1.76.

Share Price ₹337.9Jan 02,2025
Market Cap ₹3,115.4 Cr
Sales-TTM₹1,773.2 CrTTM-Consolidated Results
Price/Sales1.76xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

Definition & Calculation of PS (Price/Sales) ratio of INDOCO REMEDIES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of INDOCO REMEDIES is calculated as :

Current Market Cap [ ₹3,115.4 Cr] as on Jan 02,2025

(/) Sales [ ₹1,773.2 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 1.76x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for INDOCO REMEDIES , the investors are currently willing to pay '1.76 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of INDOCO REMEDIES !

The chart below summarizes the trend in P/S Ratio of INDOCO REMEDIES over the last five years.

Historical PS (Price/Sales) ratio chart of INDOCO REMEDIES


PS Ratio Performance Analysis for INDOCO REMEDIES

- INDOCO REMEDIES 's latest p/e ratio is 1.76x.

- INDOCO REMEDIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.92x.

- INDOCO REMEDIES 's operated at median p/e ratio of 1.8x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, INDOCO REMEDIES 's p/e ratio peaked in Mar2022 at 2.25x.

- INDOCO REMEDIES 's p/e ratio hit its five-year low in Mar2024 of 1.67x.


How does INDOCO REMEDIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
INDOCO REMEDIES 1,773.21.763,115.4
SUN PHARMACEUTICAL INDUSTRIES LTD50,307.78.96450,595.0
CIPLA LTD26,512.04.68124,175.0
DR REDDYS LABORATORIES LTD30,084.93.81114,625.0
ZYDUS LIFESCIENCES LTD21,483.54.6499,672.5
DIVIS LABORATORIES LTD8,614.018.93163,089.0
MANKIND PHARMA LTD11,018.010.86119,626.0
TORRENT PHARMACEUTICALS LTD11,225.010.39116,637.0
LUPIN LTD21,431.35.10109,327.0
AUROBINDO PHARMA LTD30,295.02.5978,329.8
ABBOTT INDIA LTD6,066.110.4963,622.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs INDOCO REMEDIES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 1.76x
Max industry PS 18.93x
Median industry PS 5.10x
Average industry PS 7.47x



You may also like the below Video Courses